glp-1 supplement crackdown news Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS investigation Lemme Inc., co-founded by Kourtney

Phase-plate cryo-EM structure of a class B GPCR-G-protein complex

Together, thats fuelled huge demand for weight loss injections and other obesity treatments and also some problems: Ongoing Ozempic shortages in Australia because of offlabel use for weight loss, leaving some people with diabetes struggling to access their medication

Just something your stomach didnt argue with

For patients with type 2 diabetes who maintained a stable weight, GLP-1 use was associated with an 8.7% lower osteoporosis risk compared to patients who did not use a GLP-1, as seen in Figure 1

Without enough saliva, bacteria multiply faster, acid levels climb, and plaque builds up at an accelerated rate